At Paradigm, we're creating a new patient-centric model for clinical trials. When more patients have the option to participate, we can achieve better care and help bring new treatments to market faster. Today we’re announcing a new collaboration with Bristol Myers Squibb: to build a new end-to-end model for clinical trials, starting in oncology. Our two organizations share a commitment to bring access to clinical trials to underserved populations and reduce the burden of trials on patients and providers – which will speed both recruitment and results. #BristolMyersSquibb #BMS Read more in our press release here --> https://lnkd.in/g4kDd8zC
Yes! It takes this kind of radical collaboration to advance equitable care and access - accelerating drug development for everyone in an unprecedented way. Congratulations to Paradigm.
Many congrats to the Paradigm and BMS teams. Exciting to see.
Simply outstanding! Well done Paradigm team!!!
Exciting! Congratulations to Paradigm and BMS!
Congratulations Kent Thoelke 🏳️🌈 and the Paradigm team! The collaboration is an exciting step forward to reduce the burden of clinical trial recruitment and operations. Stephen Knight Brett Cook